Turn off the radio and come a little closer to listen to two experts discuss some of the novel approaches to pharmacological management of ocular disease. The morning session consists of a sampling of cases that will illustrate treatment and management options for a variety of challenging conditions while the afternoon session focuses on new drug development and emerging delivery mechanisms designed to enhance efficacy of treatment.
- Paul Ajamian, OD ’80, Omni Eye Center, Atlanta, Georgia
- Michael Singer, MD, PhD, Topokine Therapeutics and Harvard Medical School
Location: New England College of Optometry
5 Hours of COPE certified CE credit
Register for the Pharmacology Fireside Chat.
Sponsored in part by the Alumni Association and